Merck & Co. Inc. (MRK) News

Merck & Co. Inc. (MRK): $81.75

0.21 (+0.26%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter MRK News Items

MRK News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MRK News Highlights

  • For MRK, its 30 day story count is now at 87.
  • Over the past 29 days, the trend for MRK's stories per day has been choppy and unclear. It has oscillated between 1 and 30.
  • DRUG, AG and IMV are the most mentioned tickers in articles about MRK.

Latest MRK News From Around the Web

Below are the latest news stories about Merck & Co Inc that investors may wish to consider to help them evaluate MRK as an investment opportunity.

Late-stage data buoys Merck's Keytruda as second-line hepatocellular carcinoma treatment

Phase 3 data from the KEYNOTE-394 data of Merck's (NYSE:MRK) Keytruda (pembrolizumab) showed improvement in overall survival ("OS"), progression-free survival ("PFS"), and objective response rate ("ORR") compared to placebo plus best supportive care in advanced hepatocellular carcinoma ("HCC") patients previously treated with Nexavar (sorafenib). Keytruda plus BSC led to a statistically significant...

Seeking Alpha | January 18, 2022

Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo in Certain Patients With Advanced Hepatocellular Carcinoma (HCC) Previously Treated With Sorafenib

KENILWORTH, N.J., January 18, 2022--KEYTRUDA Significantly Improved Overall Survival (OS) in Patients With Advanced Hepatocellular Carcinoma (HCC) Previously Treated With Sorafenib

Yahoo | January 18, 2022

Omicron: Why a fourth dose of coronavirus vaccines may not be 'absolutely necessary,' doctor says

Dr. Robert G. Lahita MD, PhD, Director of the Institute for Autoimmune and Rheumatic Disease at Saint Joseph Health and author of Immunity Strong, joins Yahoo Finance Live to discuss the latest information on COVID-19 booster vaccinations, transmissibility, and the pressures felt by hospitals in remote regions.

Yahoo | January 18, 2022

Addison Capital Co Buys Coterra Energy Inc, Intel Corp, General Motors Co, Sells iShares ...

Philadelphia, PA, based Investment company Addison Capital Co (Current Portfolio) buys Coterra Energy Inc, Intel Corp, General Motors Co, Activision Blizzard Inc, Match Group Inc, sells iShares S&P 500 Growth ETF, Peapack Gladstone Financial Corp, iShares S&P 500 Value ETF, BTC iShares Cohen & Steers REIT ETF, Medtronic PLC during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Addison Capital Co.

Yahoo | January 18, 2022

Kempner Capital Management Inc. Buys LyondellBasell Industries NV, Fidelity National ...

Galveston, TX, based Investment company Kempner Capital Management Inc. (Current Portfolio) buys LyondellBasell Industries NV, Fidelity National Information Services Inc, Amgen Inc, Skyworks Solutions Inc, ViacomCBS Inc, sells AT&T Inc, Roche Holding AG, Deutsche Telekom AG, Continental AG, Credit Suisse Group AG during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Kempner Capital Management Inc..

Yahoo | January 18, 2022

Ridgewood Investments LLC Buys Vale SA, Activision Blizzard Inc, Calavo Growers Inc, Sells ...

Investment company Ridgewood Investments LLC (Current Portfolio) buys Vale SA, Activision Blizzard Inc, Calavo Growers Inc, FedEx Corp, Takeda Pharmaceutical Co, sells General Dynamics Corp, Merck Inc, Comcast Corp, U.S.

Yahoo | January 18, 2022

Could The Merck & Co., Inc. (NYSE:MRK) Ownership Structure Tell Us Something Useful?

Every investor in Merck & Co., Inc. ( NYSE:MRK ) should be aware of the most powerful shareholder groups. Insiders...

Yahoo | January 18, 2022

Merck Animal Health's Third Veterinarian Wellbeing Study Reveals Increased Health Challenges and Psychological Distress Among Veterinarians

Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today released findings of its comprehensive study conducted in collaboration with the American Veterinary Medical Association (AVMA) examining the wellbeing and mental health of U.S. veterinarians. Conducted in the fall of 2021, the wide-ranging Veterinary Wellbeing Study is the third survey since 2017 and the first since the COVID-19 pandemic

Yahoo | January 18, 2022

UPDATE 1-Merck signs supply deal with UNICEF for 3 mln courses of COVID-19 pill

Merck & Co Inc and partner Ridgeback Biotherapeutics said on Tuesday they had signed an agreement with the United Nations Children's Fund (UNICEF) to supply up to 3 million courses of their COVID-19 antiviral pill. Merck would supply the pill, molnupiravir, to UNICEF through the first half of 2022 for distribution in more than 100 low- and middle-income countries upon regulatory authorizations, the companies said. Many countries have signed supply deals with Merck for the drug.

Yahoo | January 18, 2022

Zacks Industry Outlook Highlights: Roche, Pfizer, AbbVie and Merck

Roche, Pfizer, AbbVie and Merck are highlighted in this Industry Outlook article.

Yahoo | January 18, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5638 seconds.